Editoryal
PDF Zotero Mendeley EndNote BibTex Kaynak Göster

Montelukast in experimental animal studies

Yıl 2017, Cilt 8, Sayı 2, 1 - 1, 08.06.2017
https://doi.org/10.18663/tjcl.320026

Öz

Son yıllarda sisteinil lökotrien (CysLT1) reseptör antagonisti, allerji ve astım tedavisinde kullanılan bir ilaç olan montelukastın deneysel çalışmalarda sıklıkla kullanıldığını görmekteyiz. Bu ve benzeri birçok çalışma ışığında, ileride montelukastın farklı alanlarda kullanılacağını öngörmek zor değil. Bunların başında inflamatuar hastalıklarda kullanımı, graft versus host reaksiyonlarının tedavisi ve özellikle kanser tedavisi konusunda yapılacak çalışmalar başı çekecektir.

Kaynakça

  • 1. Budak AB, Korkmaz K, Gedik HS, et al. Effect of montelucast on hepatic and renal ischemia/reperfusion injury. Turk Clin Lab 2017; 8: 43-51.
  • 2. Jung HW, Jung JK, Park YK. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis. Int Immunopharmacol 2013; 16: 254-60.
  • 3. Ikeda G, Miyahara N, Koga H, et al. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema. Am J Respir Cell Mol Biol 2014; 50: 18-29.
  • 4. Sekioka T, Kadode M, Yonetomi Y, et al. CysLT2 receptor activation is involved in LTC4-induced lung air-trapping in guinea pigs. Eur J Pharmacol 2017; 794: 147-153.
  • 5. Tu ZL, Zhou ZY, Xu HC,et al. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats. J Cardiothorac Surg 2017; 12: 43.
  • 6. Kim BH, Park M, Park HJ, et al. Prolonged, acute suppression of cysteinyl leukotriene to reduce capsular contracture around silicone implants. Acta Biomater 2017; 51: 209-219.
  • 7. Yang JD, Kwon OH, Lee JW, et al. The effect of montelukast and antiadhesion barrier solution on the capsule formation after insertion of silicone implants in a white rat model. Eur Surg Res 2013; 51: 146-55.
  • 8. Polat A, Canbora MK, Akakin D, Aykanat F. Effects of montelukast sodium on tendon healing: An experimental study. Indian J Orthop 2013; 47: 500-4.
  • 9. Marschallinger J, Schäffner I, Klein B, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun 2015; 6: 8466.
  • 10. Kumar A, Prakash A, Pahwa D, Mishra J. Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats. Pharmacol Biochem Behav 2012; 103: 43-52.
  • 11. Kuru S, Kismet K, Barlas AM, et al. The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model. Viszeralmedizin 2015; 31: 131-8.
  • 12. Angı S, Eken H, Kılıc E, Karaköse O, Balci G, Somuncu E. Effects of Montelukast in an Experimental Model of Acute Pancreatitis. Med Sci Monit 2016; 22: 2714-9.
  • 13. Eskicioğlu F, Turan GA, Sivrikoz ON, et al. Montelukast is effective in preventing of ovarian hyperstimulation syndrome; an experimental study. Ginekol Pol 2015; 86: 566-73.
  • 14. Cavus G, Altas M, Aras M, et al. Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats. Eur Rev Med Pharmacol Sci 2014; 18: 1770-7.
  • 15. Genovese T, Rossi A, Mazzon E, et al. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol 2008; 153: 568-82.
  • 16. Uçar S, Huseynov T, Çoban M, Sarıoğlu S, Serbetçioğlu B, Yalcin AD. Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study. Med Sci Monit Basic Res 2013; 19: 246-52.
  • 17. Savari S, Liu M, Zhang Y, Sime W, Sjölander A. CysLT(1) R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS One 2013; 8: e73466.

Deneysel hayvan çalışmalarında montelukast

Yıl 2017, Cilt 8, Sayı 2, 1 - 1, 08.06.2017
https://doi.org/10.18663/tjcl.320026

Öz

Son yıllarda sisteinil lökotrien (CysLT1) reseptör antagonisti, allerji ve astım tedavisinde kullanılan bir ilaç olan montelukastın deneysel çalışmalarda sıklıkla kullanıldığını görmekteyiz. Bu ve benzeri birçok çalışma ışığında, ileride montelukastın farklı alanlarda kullanılacağını öngörmek zor değil. Bunların başında inflamatuar hastalıklarda kullanımı, graft versus host reaksiyonlarının tedavisi ve özellikle kanser tedavisi konusunda yapılacak çalışmalar başı çekecektir.

Kaynakça

  • 1. Budak AB, Korkmaz K, Gedik HS, et al. Effect of montelucast on hepatic and renal ischemia/reperfusion injury. Turk Clin Lab 2017; 8: 43-51.
  • 2. Jung HW, Jung JK, Park YK. Comparison of the efficacy of KOB03, ketotifen, and montelukast in an experimental mouse model of allergic rhinitis. Int Immunopharmacol 2013; 16: 254-60.
  • 3. Ikeda G, Miyahara N, Koga H, et al. Effect of a cysteinyl leukotriene receptor antagonist on experimental emphysema and asthma combined with emphysema. Am J Respir Cell Mol Biol 2014; 50: 18-29.
  • 4. Sekioka T, Kadode M, Yonetomi Y, et al. CysLT2 receptor activation is involved in LTC4-induced lung air-trapping in guinea pigs. Eur J Pharmacol 2017; 794: 147-153.
  • 5. Tu ZL, Zhou ZY, Xu HC,et al. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats. J Cardiothorac Surg 2017; 12: 43.
  • 6. Kim BH, Park M, Park HJ, et al. Prolonged, acute suppression of cysteinyl leukotriene to reduce capsular contracture around silicone implants. Acta Biomater 2017; 51: 209-219.
  • 7. Yang JD, Kwon OH, Lee JW, et al. The effect of montelukast and antiadhesion barrier solution on the capsule formation after insertion of silicone implants in a white rat model. Eur Surg Res 2013; 51: 146-55.
  • 8. Polat A, Canbora MK, Akakin D, Aykanat F. Effects of montelukast sodium on tendon healing: An experimental study. Indian J Orthop 2013; 47: 500-4.
  • 9. Marschallinger J, Schäffner I, Klein B, et al. Structural and functional rejuvenation of the aged brain by an approved anti-asthmatic drug. Nat Commun 2015; 6: 8466.
  • 10. Kumar A, Prakash A, Pahwa D, Mishra J. Montelukast potentiates the protective effect of rofecoxib against kainic acid-induced cognitive dysfunction in rats. Pharmacol Biochem Behav 2012; 103: 43-52.
  • 11. Kuru S, Kismet K, Barlas AM, et al. The Effect of Montelukast on Liver Damage in an Experimental Obstructive Jaundice Model. Viszeralmedizin 2015; 31: 131-8.
  • 12. Angı S, Eken H, Kılıc E, Karaköse O, Balci G, Somuncu E. Effects of Montelukast in an Experimental Model of Acute Pancreatitis. Med Sci Monit 2016; 22: 2714-9.
  • 13. Eskicioğlu F, Turan GA, Sivrikoz ON, et al. Montelukast is effective in preventing of ovarian hyperstimulation syndrome; an experimental study. Ginekol Pol 2015; 86: 566-73.
  • 14. Cavus G, Altas M, Aras M, et al. Effects of montelukast and methylprednisolone on experimental spinal cord injury in rats. Eur Rev Med Pharmacol Sci 2014; 18: 1770-7.
  • 15. Genovese T, Rossi A, Mazzon E, et al. Effects of zileuton and montelukast in mouse experimental spinal cord injury. Br J Pharmacol 2008; 153: 568-82.
  • 16. Uçar S, Huseynov T, Çoban M, Sarıoğlu S, Serbetçioğlu B, Yalcin AD. Montelukast is as effective as penicillin in treatment of acute otitis media: an experimental rat study. Med Sci Monit Basic Res 2013; 19: 246-52.
  • 17. Savari S, Liu M, Zhang Y, Sime W, Sjölander A. CysLT(1) R antagonists inhibit tumor growth in a xenograft model of colon cancer. PLoS One 2013; 8: e73466.

Ayrıntılar

Konular Sağlık Bilimleri ve Hizmetleri
Yayınlanma Tarihi haziran
Bölüm Baş yazı
Yazarlar

Berkant Özpolat

Yayımlanma Tarihi 8 Haziran 2017
Yayınlandığı Sayı Yıl 2017, Cilt 8, Sayı 2

Kaynak Göster

Bibtex @editoryal { tjcl320026, journal = {Turkish Journal of Clinics and Laboratory}, issn = {}, eissn = {2149-8296}, address = {}, publisher = {DNT Ortadoğu Yayıncılık A.Ş.}, year = {2017}, volume = {8}, pages = {1 - 1}, doi = {10.18663/tjcl.320026}, title = {Deneysel hayvan çalışmalarında montelukast}, key = {cite}, author = {Özpolat, Berkant} }
APA Özpolat, B. (2017). Deneysel hayvan çalışmalarında montelukast . Turkish Journal of Clinics and Laboratory , 8 (2) , 1-1 . DOI: 10.18663/tjcl.320026
MLA Özpolat, B. "Deneysel hayvan çalışmalarında montelukast" . Turkish Journal of Clinics and Laboratory 8 (2017 ): 1-1 <https://dergipark.org.tr/tr/pub/tjcl/issue/29774/320026>
Chicago Özpolat, B. "Deneysel hayvan çalışmalarında montelukast". Turkish Journal of Clinics and Laboratory 8 (2017 ): 1-1
RIS TY - JOUR T1 - Deneysel hayvan çalışmalarında montelukast AU - Berkant Özpolat Y1 - 2017 PY - 2017 N1 - doi: 10.18663/tjcl.320026 DO - 10.18663/tjcl.320026 T2 - Turkish Journal of Clinics and Laboratory JF - Journal JO - JOR SP - 1 EP - 1 VL - 8 IS - 2 SN - -2149-8296 M3 - doi: 10.18663/tjcl.320026 UR - https://doi.org/10.18663/tjcl.320026 Y2 - 2022 ER -
EndNote %0 Turkish Journal of Clinics and Laboratory Deneysel hayvan çalışmalarında montelukast %A Berkant Özpolat %T Deneysel hayvan çalışmalarında montelukast %D 2017 %J Turkish Journal of Clinics and Laboratory %P -2149-8296 %V 8 %N 2 %R doi: 10.18663/tjcl.320026 %U 10.18663/tjcl.320026
ISNAD Özpolat, Berkant . "Deneysel hayvan çalışmalarında montelukast". Turkish Journal of Clinics and Laboratory 8 / 2 (Haziran 2017): 1-1 . https://doi.org/10.18663/tjcl.320026
AMA Özpolat B. Deneysel hayvan çalışmalarında montelukast. TJCL. 2017; 8(2): 1-1.
Vancouver Özpolat B. Deneysel hayvan çalışmalarında montelukast. Turkish Journal of Clinics and Laboratory. 2017; 8(2): 1-1.
IEEE B. Özpolat , "Deneysel hayvan çalışmalarında montelukast", Turkish Journal of Clinics and Laboratory, c. 8, sayı. 2, ss. 1-1, Haz. 2017, doi:10.18663/tjcl.320026


e-ISSN: 2149-8296

The content of this site is intended for health care professionals. All the published articles are distributed under the terms of

Creative Commons Attribution Licence,

which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.